Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07653750Terminated
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoints: Serum measurements: CHI3L1 and NGAL-MMP9 at 12 months and Fecal measurements: CHI3L1, MMP9 at 12 months. Started Jun 2021; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07653750.